Every person is different
People began calling their results "remarkable" and "life-changing." Over time, LifeWave conducted multiple clinical studies on X39, including double-blind trials measuring things like copper peptide levels in the blood, brain coherence via EEG scans, and improvements in sleep and recovery markers
Individuals with a BMI over 25 and metabolic concerns, or a BMI over 30, may be eligible following a medical evaluation
A lot of the papers looking at these drugs and their impact on immunity have shown that people who take them respond better to infections, they have better outcomes in the context of fighting different types of cancer, but no one has looked at what is directly happening to the immune cells, says Claire Pillsbury, PhD, a postdoctoral fellow working in the lab of cancer center leader Curtis Henry, PhD